Burning Rock Biotech (BNR) Invested Capital (2019 - 2025)

Burning Rock Biotech's Invested Capital history runs 7 years deep, the most recent figure standing at $75.5 million for Q4 2025.

• In Q4 2025, Invested Capital fell 6.63% year-over-year to $75.5 million; the TTM figure through Dec 2025 stood at $75.5 million (down 6.63% YoY), while the FY2025 annual figure was $75.5 million, down 5.12% from the prior year.
• Invested Capital was $75.5 million for Q4 2025 at Burning Rock Biotech, down from $76.8 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $361.2 million in Q1 2021 to a low of $75.5 million in Q4 2025.
• Historically, Invested Capital has averaged $166.3 million across 5 years, with a median of $128.2 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Invested Capital sank 43.64% in 2022, then decreased 6.63% in 2025.
• A 5-year view of Invested Capital shows it stood at $289.0 million in 2021, then plunged by 43.64% to $162.9 million in 2022, then tumbled by 34.47% to $106.7 million in 2023, then fell by 24.23% to $80.9 million in 2024, then declined by 6.63% to $75.5 million in 2025.
• The last three Invested Capital figures came in at $75.5 million (Q4 2025), $76.8 million (Q3 2025), and $78.0 million (Q2 2025), per Business Quant data.